Ephedrine Treatment for Autoimmune Myasthenia Gravis
Neuromuscular Disorders - United Kingdom
doi 10.1016/j.nmd.2016.11.009
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2017
Authors
Publisher
Elsevier BV
Available in full text
March 1, 2017
Elsevier BV